157 related articles for article (PubMed ID: 20925909)
21. RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB.
Reinhold WC; Varma S; Sunshine M; Elloumi F; Ofori-Atta K; Lee S; Trepel JB; Meltzer PS; Doroshow JH; Pommier Y
Cancer Res; 2019 Jul; 79(13):3514-3524. PubMed ID: 31113817
[TBL] [Abstract][Full Text] [Related]
22. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
[TBL] [Abstract][Full Text] [Related]
23. Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays.
Guttman M; Mies C; Dudycz-Sulicz K; Diskin SJ; Baldwin DA; Stoeckert CJ; Grant GR
PLoS Genet; 2007 Aug; 3(8):e143. PubMed ID: 17722985
[TBL] [Abstract][Full Text] [Related]
24. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
25. Latent factor analysis to discover pathway-associated putative segmental aneuploidies in human cancers.
Lucas JE; Kung HN; Chi JT
PLoS Comput Biol; 2010 Sep; 6(9):e1000920. PubMed ID: 20824128
[TBL] [Abstract][Full Text] [Related]
26. Collective effects of long-range DNA methylations predict gene expressions and estimate phenotypes in cancer.
Kim S; Park HJ; Cui X; Zhi D
Sci Rep; 2020 Mar; 10(1):3920. PubMed ID: 32127627
[TBL] [Abstract][Full Text] [Related]
27. CellMiner: a relational database and query tool for the NCI-60 cancer cell lines.
Shankavaram UT; Varma S; Kane D; Sunshine M; Chary KK; Reinhold WC; Pommier Y; Weinstein JN
BMC Genomics; 2009 Jun; 10():277. PubMed ID: 19549304
[TBL] [Abstract][Full Text] [Related]
28. Integrated metabolome and transcriptome analysis of the NCI60 dataset.
Su G; Burant CF; Beecher CW; Athey BD; Meng F
BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S36. PubMed ID: 21342567
[TBL] [Abstract][Full Text] [Related]
29. Identifying direct miRNA-mRNA causal regulatory relationships in heterogeneous data.
Zhang J; Le TD; Liu L; Liu B; He J; Goodall GJ; Li J
J Biomed Inform; 2014 Dec; 52():438-47. PubMed ID: 25181465
[TBL] [Abstract][Full Text] [Related]
30. A systematic comparison of copy number alterations in four types of female cancer.
Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
[TBL] [Abstract][Full Text] [Related]
31. CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics.
Luna A; Elloumi F; Varma S; Wang Y; Rajapakse VN; Aladjem MI; Robert J; Sander C; Pommier Y; Reinhold WC
Nucleic Acids Res; 2021 Jan; 49(D1):D1083-D1093. PubMed ID: 33196823
[TBL] [Abstract][Full Text] [Related]
32. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
[TBL] [Abstract][Full Text] [Related]
33. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
Culhane AC; Perrière G; Higgins DG
BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
[TBL] [Abstract][Full Text] [Related]
34. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
[TBL] [Abstract][Full Text] [Related]
35. [Exploration of novel molecular targets for cancer therapy based on genomic aberrations].
Imoto I; Inazawa J
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1891-4. PubMed ID: 16282722
[TBL] [Abstract][Full Text] [Related]
36. InterSIM: Simulation tool for multiple integrative 'omic datasets'.
Chalise P; Raghavan R; Fridley BL
Comput Methods Programs Biomed; 2016 May; 128():69-74. PubMed ID: 27040832
[TBL] [Abstract][Full Text] [Related]
37. Network-based integration of multi-omics data for prioritizing cancer genes.
Dimitrakopoulos C; Hindupur SK; Häfliger L; Behr J; Montazeri H; Hall MN; Beerenwinkel N
Bioinformatics; 2018 Jul; 34(14):2441-2448. PubMed ID: 29547932
[TBL] [Abstract][Full Text] [Related]
38. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
39. A Linear Regression and Deep Learning Approach for Detecting Reliable Genetic Alterations in Cancer Using DNA Methylation and Gene Expression Data.
Mallik S; Seth S; Bhadra T; Zhao Z
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806782
[TBL] [Abstract][Full Text] [Related]
40. Massive NGS data analysis reveals hundreds of potential novel gene fusions in human cell lines.
Gioiosa S; Bolis M; Flati T; Massini A; Garattini E; Chillemi G; Fratelli M; Castrignanò T
Gigascience; 2018 Oct; 7(10):. PubMed ID: 29860514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]